THE TREND INTELLIGENCE PLATFORM FOR LIFE SCIENCES
Spot the next breakout in pharma, biotech & healthcare — before consensus.
Morning Pharma is the data layer that surfaces emerging therapeutic categories, modalities, indications and companies — purpose-built for life-science investors, marketers, consultants and journalists.
Used by analysts at
- Pemberton Bio
- Hillridge Healthcare
- Caspian Strategy
- Northshield Capital
Radioligand therapy
5-year search-volume signal
LIVE TRENDS
Trending right now in life sciences
Twelve trends moving fastest across our pharma, biotech and healthcare signal universe. Filter by category, sort by growth, drill into the analysis.
Cardiometabolic & Obesity·Medtech
ExplodingPulsed-field ablation
- 5y growth
- +760%
- monthly volume
- 16K /mo
Radioligand & Theranostics·Modality
ExplodingTargeted alpha emitters
- 5y growth
- +694%
- monthly volume
- 5.1K /mo
Cardiometabolic & Obesity·Therapeutic class
ExplodingPCSK9 oral inhibitors
- 5y growth
- +670%
- monthly volume
- 6.9K /mo
Radioligand & Theranostics·Modality
ExplodingRadioligand therapy in mCRPC
- 5y growth
- +626%
- monthly volume
- 13K /mo
Cell & Gene Therapy·Modality
ExplodingCRISPR base editing for sickle cell
- 5y growth
- +619%
- monthly volume
- 8.6K /mo
Cardiometabolic & Obesity·Therapeutic class
ExplodingLP(a)-lowering therapeutics
- 5y growth
- +596%
- monthly volume
- 4.2K /mo
Cardiometabolic & Obesity·Modality
ExplodingOral GLP-1 receptor agonists
- 5y growth
- +564%
- monthly volume
- 38K /mo
AI in Drug Discovery·Platform
ExplodingAI-designed biologics
- 5y growth
- +544%
- monthly volume
- 15K /mo
Vaccines & Infectious Disease·Modality
ExplodingLong-acting HIV PrEP
- 5y growth
- +533%
- monthly volume
- 7.8K /mo
Neuroscience & CNS·Workflow
ExplodingDigital biomarkers in CNS trials
- 5y growth
- +527%
- monthly volume
- 5.7K /mo
Oncology·Modality
RegularADC payload diversification
- 5y growth
- +511%
- monthly volume
- 9.7K /mo
Manufacturing & CDMO·Capability
RegularCDMO capacity for cell therapies
- 5y growth
- +487%
- monthly volume
- 4.2K /mo
WHY MORNING PHARMA
A research stack purpose-built for life sciences
Built only on life-sciences signals
We ingest clinical-trial registries, FDA / EMA / PMDA filings, biomedical literature, patent flows, conference abstracts, congress chatter, biotech funding rounds and HCP / patient search behavior — nothing else.
Trend-grade, not news-grade
We separate durable category shifts (radioligands, oral GLP-1s, in vivo CAR-T) from short-lived hype, so you act on a thesis rather than a headline.
Built for decisions worth millions
Whether you're sizing a Series B, briefing a CMO or shaping a launch narrative, every chart is exportable, every claim is sourced and every datapoint is timestamped.
WHO IT IS FOR
What you can do with Morning Pharma
Build a defensible breakout thesis before the next term sheet.
- Track emerging modalities and platforms across radioligands, oral GLP-1s, in vivo CAR-T and 14 more
- Surface clinical-stage companies before late-Series rounds price them in
- Watch competitor pipelines and licensing flow weekly
- Export trend curves directly into your IC memo
Breakout startups · Radioligand therapy
- #1Verana Therapeutics+612%EXPLODING
- #2Pemberton Theranostics+428%EXPLODING
- #3Hillridge Bio+241%REGULAR
- #4Caspian Radiopharm+188%REGULAR
- #5Northshield Oncology+96%REGULAR
META TRENDS
The reports that brief the conversation
Long-form analyses across the categories quietly compounding into the next decade of life-sciences investment.
Updated April 2026
The Post-GLP-1 Pipeline: 47 Programs Reshaping Cardiometabolic Care
A category map of the next-generation oral, dual-agonist and tissue-restricted programs that follow the obesity wave.
Read the reportUpdated March 2026
Radioligand Therapy 2026: The 12 Companies Defining the Category
PSMA, FAP, SSTR and the targets coming behind them — supply, payload chemistry, and the names locking down isotope flow.
Read the reportUpdated February 2026
AI-Designed Biologics: From Hype to IND in 18 Months
Generative protein design has crossed from research toy to credible drug-discovery platform — a technical and commercial map.
Read the report
BROWSE
16 categories, one signal layer
From oncology and cardiometabolic to manufacturing and market access — the surface area where life-science decisions are made.
Oncology
3 trends tracked
Cardiometabolic & Obesity
4 trends tracked
Neuroscience & CNS
3 trends tracked
Immunology & Inflammation
2 trends tracked
Rare & Genetic Diseases
1 trends tracked
Cell & Gene Therapy
2 trends tracked
Radioligand & Theranostics
2 trends tracked
Vaccines & Infectious Disease
2 trends tracked
Women's Health
1 trends tracked
Mental & Behavioral Health
1 trends tracked
Digital Therapeutics & SaMD
1 trends tracked
AI in Drug Discovery
2 trends tracked
Clinical Trial Innovation
2 trends tracked
Manufacturing & CDMO
2 trends tracked
Regulatory & Market Access
1 trends tracked
Healthcare Investment & M&A
1 trends tracked
Trusted by teams analyzing the future of life sciences
- Logo
- Logo
- Logo
- Logo
- Logo
- Logo
- Logo
- Logo
TESTIMONIALS
How life-science teams use Morning Pharma
“I caught the radioligand wave eight months before our usual research stack picked it up. The breakout view paid for itself on a single Series B.”
“Morning Pharma is the only tool that lets me brief our CMO on the patient narrative shift in obesity — with a chart, a date and a citation she can't argue with.”
“We rebuilt our cell-and-gene-therapy practice's trend deck on Morning Pharma exhibits. Three engagements that quarter cited it directly.”
PRICING
Choose how your team uses the signal
Three tiers. No data caps on the categories you care about.
Analyst
For individual journalists & consultants
$—/ mo- Full trend feed and 5y history
- Track up to 25 topics
- Weekly briefing
- CSV export
- MOST POPULAR
Team
For marketing & strategy teams
$—/ mo- Everything in Analyst
- Up to 10 seats
- Branded export templates
- Saved filters and alerts
- API access
Enterprise
For VC funds & global pharma
Custom- Everything in Team
- SSO / SAML
- Custom data integrations
- Dedicated success engineer